A division of S Kant HEALTHCARE Ltd.
We are a research and innovation driven enterprise, uniquely engaged in developing novel healthcare solutions from natural sources including plants, nutraceuticals etc. We follow stringent norms for standardisation, validation and product development ensuring world class quality and consistent performance; thus applying the rigors of modern science to the goodness of nature origin products.
Ekắhetu plans to leverage India’s biodiversity and vast pool of knowledge in traditional medicinal systems such as Ayurveda as a source of new medications. The division has a unique and diverse collections ancient wisdom through various age-old texts as well as practitioners with more than 7 decades of clinical experience.
Ekắhetu’s discovery and development process includes evaluation and investigation of plant extracts/preparations for the therapeutic potential and safety, standardization and validation of promising candidates into commercial scales bioactives, formulation development and clinical trials. The process results in standardised, evidence based Nature origin products that are at par with pharma products in terms of consistent performance and quality yet preserve the holistic properties of natural products.
Ekắhetu this hopes to address unmet medical need with Nature origin products by applying modern science and clinical validation techniques. Ekắhetu plans to be vertically integrated division with the capability to develop new products from discovery through clinical development and launch worldwide through established distribution network. At the same time, the management is open for partnerships that can accelerate the commercialisation & world-wide availability of Ekắhetu’s range of “Nature Origin Products”.
Ekắhetu is a part of the over USD 1 billion S Kant group, one of the India’s largest diversified business houses. The flagship company of the Group, S Kant HEALTHCARE Ltd has manufacturing plants – spread across 11 acres (45,000 sq. metres approximately) with EU-GMP and WHO-GMP approvals and has global presence in over 90 countries with over 1,500 valid product registrations / under registration globally. S Kant HEALTHCARE Ltd is also preferred supplier to various International Organizations including Mission Pharma (Denmark), Imres (Netherlands), MEG (Netherlands), Troge (Germany), IDA (Netherlands), PAHO (USA), PFSCMS (USA), UNICEF, WHO, (Geneva), Etc.